myirislogo
26 November, 2014 13:05 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 306.25 0.43
Sun Pharma 837.55 0.32
Bhel 269.70 1.70
Tata Power 90.80 0.72
I T C 361.10 1.52
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Brooks Laboratories Limited
Brooks Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:533543NSE:BROOKSBloomberg:BKL@INReuters:BROO.BO
Market Lot: 1Face Value: 10ISIN Demat: INE650L01011
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
08-DEC-11 Brooks Laboratories has received approval for manufacture of Doripenem Monohydrate Injection from Directorate General of Health Service. The company is all set to manufacture this drug within this fiscal year. Future Plans The company now plans to set up a new manufacturing unit at Panoli, Gujarat for manufacturing formulations with an investment of Rs 520 million. Also, Rs 50 million from IPO proceeds will be utilized towards lon...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Brooks Lab gets nod for Doripenem Monohydrate from DGHS  -IRIS 08-Dec-11
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)
Net sales
Other Income
Total Income
Cost of goods sold
OPBDIT
PAT
Gross Block
Equity capital
EPS (Rs.)
DPS (Rs.)
BV (Rs.)
P/E range (x)
Debt / Equity (x)
Operating margin (% of OI)
Net margin (% of OI)
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
G-101, Ivory Tower
Sector 70
Mohali
Punjab-160 055
PHONE
(0172) 5097 355
FAX
(0172) 5097 355
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer